Literature DB >> 24727890

Acute Basilar Artery Occlusion with Underlying High-Grade Basilar Artery Stenosis: Multimodal Endovascular Therapy in a Series of Seven Patients.

D Behme1, W Weber, A Mpotsaris.   

Abstract

PURPOSE: Acute basilar artery occlusion is associated with high rates of major morbidity and mortality. In rare cases, the underlying pathology is a high-grade stenosis of the basilar artery. We report on a series of seven cases with occluded high-grade basilar artery stenosis who received endovascular therapy at our center.
MATERIAL AND METHODS: Our prospective database since October 2009 until September 2013 was screened for patients with acute basilar artery occlusion and underlying high-grade stenosis who underwent endovascular therapy. Case files were retrospectively reviewed for clinical, outcome, and technical data.
RESULTS: Seven patients were identified who suffered from an acute basilar artery occlusion based on a high-grade stenosis between October 2009 and September 2013. These patients were treated with an acute stenting of the basilar artery with or without a preceding mechanical thrombectomy. Median age was 75 (53-83) years; median prethrombectomy National Institute of Health Stroke scale score was 19 (7-28). A successful recanalization result defined as modified Thrombolysis In Cerebral Infarction grade 2b or higher was achieved in all cases. Two of the seven patients had a procedural complication consisting of a vessel dissection after angioplasty. A good clinical outcome according to the Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT) study criteria was achieved in three of the seven patients. One patient died during hospitalization in the acute phase.
CONCLUSION: Mechanical thrombectomy combined with acute stenting of the basilar artery is technically feasible and may be an effective therapeutic option in the rare case of an acutely occluded high-grade stenosis of the basilar artery in patients with an otherwise poor prognosis.

Entities:  

Mesh:

Year:  2014        PMID: 24727890     DOI: 10.1007/s00062-014-0303-9

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  9 in total

1.  Technical feasibility and application of mechanical thrombectomy with the Solitaire FR Revascularization Device in acute basilar artery occlusion.

Authors:  P Mordasini; C Brekenfeld; J V Byrne; U Fischer; M Arnold; M R Heldner; R Lüdi; H P Mattle; G Schroth; J Gralla
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-21       Impact factor: 3.825

2.  Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis.

Authors:  Osama O Zaidat; Tony P Smith; Michael J Alexander
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

Review 3.  Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience.

Authors:  E F Wijdicks; D A Nichols; K R Thielen; J R Fulgham; R D Brown; I Meissner; F B Meyer; D G Piepgras
Journal:  Mayo Clin Proc       Date:  1997-11       Impact factor: 7.616

4.  Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.

Authors:  Jeffrey L Saver; Reza Jahan; Elad I Levy; Tudor G Jovin; Blaise Baxter; Raul G Nogueira; Wayne Clark; Ronald Budzik; Osama O Zaidat
Journal:  Lancet       Date:  2012-08-26       Impact factor: 79.321

5.  Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.

Authors:  V N Thijs; G W Albers
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Basilar artery stenosis: middle and distal segments.

Authors:  M S Pessin; P B Gorelick; E S Kwan; L R Caplan
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

8.  Mechanical thrombectomy with the Solitaire device in acute basilar artery occlusion.

Authors:  Isabelle Mourand; Paolo Machi; Didier Milhaud; Marie-Christine Picot; Kyriakos Lobotesis; Caroline Arquizan; Vincent Costalat; Chérif Héroum; Denis Sablot; Stéphane Bouly; Thibault Lalu; Alain Bonafé
Journal:  J Neurointerv Surg       Date:  2013-05-04       Impact factor: 5.836

9.  Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.

Authors:  Osama O Zaidat; Albert J Yoo; Pooja Khatri; Thomas A Tomsick; Rüdiger von Kummer; Jeffrey L Saver; Michael P Marks; Shyam Prabhakaran; David F Kallmes; Brian-Fred M Fitzsimmons; J Mocco; Joanna M Wardlaw; Stanley L Barnwell; Tudor G Jovin; Italo Linfante; Adnan H Siddiqui; Michael J Alexander; Joshua A Hirsch; Max Wintermark; Gregory Albers; Henry H Woo; Donald V Heck; Michael Lev; Richard Aviv; Werner Hacke; Steven Warach; Joseph Broderick; Colin P Derdeyn; Anthony Furlan; Raul G Nogueira; Dileep R Yavagal; Mayank Goyal; Andrew M Demchuk; Martin Bendszus; David S Liebeskind
Journal:  Stroke       Date:  2013-08-06       Impact factor: 7.914

  9 in total
  2 in total

1.  Isolated Focal Basilar Artery Stenosis with Acute Stroke Treated with Emergency Thrombectomy and Stenting.

Authors:  Karan Daga; Manish Taneja; Mohammad Taqueer Ahmad; Narayanaswamy Venketasubramanian
Journal:  Case Rep Neurol       Date:  2020-12-14

2.  Emergency Intracranial Stenting in Acute Stroke: Predictors for Poor Outcome and for Complications.

Authors:  Christian Paul Stracke; Jens Fiehler; Lukas Meyer; Götz Thomalla; Lars Udo Krause; Stephan Lowens; Jan Rothaupt; Byung Moon Kim; Ji Hoe Heo; Leonard L L Yeo; Tommy Andersson; Christoph Kabbasch; Franziska Dorn; Rene Chapot; Uta Hanning
Journal:  J Am Heart Assoc       Date:  2020-03-03       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.